研究・業績

2020年度

2020年度業績

  1. Mori T, Kikuchi T, Kato J, Koda Y, Sakurai M, Kikumi O, Inose R, Murata M, Hasegawa N, Nakayama H, Yamazaki R, Okamoto S. Seasonal changes in indoor airborne fungal concentration in a hematology ward. Journal of Infection and Chemotherapy. 26(4):363-366,2020.
  2. Ishii M, Terai H,Kabata H, Masaki K, Chubachi S, Tateno H, Nakamura M, Nishio K, Koh H, Watanabe R, Ueda S, Tarashima T, Suzuki Y, Yagi K, Miyao N, Minematsu N, Inoue T, Nakachi I, Namkoong H, Okamori S, Ikemura S, Kamata H, Yasuda H, Kawada I, Hasegawa N, Fukunaga K. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospectibe study. J Infect,81(5):e3-e5,2020.
  3. Uwamino Y, Sakai A, Nishimura T, Noguchi M, Uno S, Fujiwara H, Mori M, Wakui M, Murata M, Hasegawa N. Effect of refrigeration of blood samples in lithium-heparin tubes on QuantiFERON TB Gold Plus test result. Journal of Infection and Chemotherapy. 26(3):312-314,2020.
  4. Suzuki S, Ishii M, Asakura T, Namkoong H, Okamori S, Yagi K, Kamata H, Kusumoto T, Kagawa S, Hegab A E, Yoda M,Horiuchi K, Hasegawa N, Betsuyaku T. ADAM17 protects against elastase-induced emphysema by suppressing CD62L+ leukocyte infiltration in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2020.
  5. Yazawa S, Hasegawa, N, Oya M. Editorial Comment to Comparison of single-and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection. International journal of urology: official journal of the Japanese Urological Association. 27(3):248,2020.
  6. Gu Y, Fujitomo Y, Soeda H Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in Japan. Journal of Infection and Chemotherapy. 26(2):149-156,2020.
  7. Kawakami N, Namkoong H, Shimoda M, Kotani H, Fujiwara H, Hasegawa N. Hidden disseminated extracutaneous AIDS-related Kaposi sarcoma. IDCases. 19: e00716, 2020.
  8. Toyama T, Mori T, Kato J, Sugita K, Hasegawa N, Nakata N, Hoshino Y, Okamoto S. Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation. Transplant Infect Dis. e13278, 2020.
  9. Miyama H, Takatsuki S, Fukano H, Uwamino Y, Hasegawa N. Infection of a Cardiac Implantable Electronic Device Caused by Mycolicibacterium litorale. JACC: Case Reports. 2(2), 2020.
  10. Izumi K, Morimoto K, Uchimura K, Ato M, Hasegawa N, Mitarai S. Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease. ERJ Open Res. 6(1):00097-2019, 2020.
  11. Nishimura T, Shimoda M, Tamizu E, Uno S, Uwamino Y, Kashimura S, Yano I, Hasegawa N. The rough colony morphotype of Mycobacterium avium exhibits high virulence in human macrophages and mice. J Med Microbiol. 69(7):1020-1033, 2020.
  12. Uwamino Y, Nishimura T, Sato Y, Tamizu E, Uno S, Mori M, Fujiwara H, Kawabe H, Murata M, Hasegawa N. Showering is associated with Mycobacterium avium complex lung disease: An observational study in Japanese women. J Infect Chemother. 26(3):211-214, 2020.
  13. Nishimura T, Ota M, Mori M, Takano Y, Fujiwara H, Uwamino Y, Uno S, Hasegawa N. The annual risk of tuberculosis infection in newly hired researchers and healthcare workers using interferon -gamma release assay in Japan. J Infect Chemother.26(8):818-822, 2020.
  14. Kondo Y, Kaneko Y, Oshige T, Fukui H, Saito S, Okayama M, Kamata H, Ishii M, Hasegawa N, Fukunaga K, Takeuchi T. Exacerbati of immune thrombocytopaenia triggered by COVID-19 in patients wth systemic lupus erythematosus. Ann Rheum Dis annrheumdis-2020-218157, 2020.
  15. Nakagawa K, Masaki K, Uwamino Y, Kabata H, Uchida S, Uno S, Asakura T, Funakoshi T, Kanzaki S, Ishii M, Hasegawa N, Fukunaga K. Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections. Int J Infect Dis. S1201-9712(20)30578-6,2020.
  16. Matsuda S, Asakura T, Morimoto K, Suzuki S, Fujiwara K, Furuuchi K, Osawa T, Namkoong H, Ishii M, Kurashima A, Tatsumi K, Ohat K, Hasegawa N, Sasaki Y. Clinical significance of anti-GPL core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease. Respir Med 171:106086, 2020.
  17. Uno S, Asakura T, Morimoto K, Yoshimura K, Uwamino Y, Nishimura T, Hoshino Y, Hasegawa N & NTM JRC. Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis. BMC Pulm Med. 20: 262 , 2020.
  18. Fukano H, Miyama H, Takatsuki S, Hirabayashi A, Suzuki M, Yoshida M, Uwamino Y, Hasegawa N, Hoshino Y. Complete Genome Sequence of Mycolicibacterium sp. Strain NIID-NTM18,Isolated from Cardiac Implantable Electronic Device Infection and Most Similar to Mycolicibacterium littorale. Microbiol resour Announc.9(36):e00830-20,2020.
  19. Van Ingen J, Aliberti S, Andrejak C, D Chalmers J, R Codecasa L, L Daley C, Hasegawa N, E Griffith D, Hoefsloot W, Huitt G, Jarand J, Woo Jhun B, R Loebinger M, K Marras T, Morimoto K, Polverino E, C Ringshausen F, Santin M, Thomson R, Wagner D, J Wallace R, L Winthrop K, Jae-Joon Yim, NTM-NET. Management od drug toxicity in M.avium complex pulmonary disease-an expert panel survey. Clin Infect Dis.ciaa1361,2020.
  20. Mori T, Mikita K, Koda Y, Sakurai M, Saburi M, Hasegawa N, Kato J. Seroprevalence of Toxoplasma gondii among Japanese adults with hematological disease. Int J Hematol.112(5):755-756,2020.
  21. Uwamino Y, Nagata M, Aoki W, Fujimori Y, Nakagawa T, Yokota H, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Shiraki T, Uchida S, Uno S, Kabata H, Ikemura S, Kamata H, Ishii M, Fukunaga K, Kawaoka Y, Hasegawa N, Murata M. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2.J Clin Pathol. 206972,2020.
  22. Kondo T, Okabayashi K, Sugiura K, Obara H, Takeuchi H, Wada N, Takano Y, Iwata S, Haseagwa N, Kitagawa Y. Effectiveness of active nasal surveillance culture for Methicillin-resistant Staphylococcus aureus in patients undergoing colorectal surgery. J Infect Chemother.26(12):1244-1248,2020.
  23. Harada S, Uno S, Ando T, Iida M, Takano Y, Ishibashi Y, Uwamino Y, Nishimura T, Takeda A, Uchida S, Hirata A, Sata M, Matsumoto M, Takeuchi A, Obara H, Yokoyama H, Fukunaga K, Amagai M, Kitagawa Y, Takebayashi T, Hasegawa N. Control of a Nosocomial Outbreak of COVID-19 in a University Hospital. Open Forum Infect Dis. 7(12):ofaa512,2020.
  24. IshiiM, Terai H, Kabaa, Masaki K, Chubachi S, Tateno H, Nakamura M, Nishio K, Koh H, Watanabe R, Ueda S, Terashima T, Suzuki Y, Yagi K, Miyao N, Minematsu N, Inoue T, Nakachi I, Namkoong H, Okamori S, Ikemura S, Kamata H, Yasuda H, Kawada I, Hasegawa N, Fukunaga K; Keio COVID-19 Research Consortium (K-CORC) and the Keio Donner Project Team. Clinical characteristics of 345 patients with J Infect 81(5):e3-e5, 2020
  25. Hase R, Yokoyama Y, Suzuki H, Uno S, Mikawa T, Suzuki D, Muranaka K, Hosokawa N. Review of the First Comprehensive Outpatient Parenteral Antimicrobial Therapy Program in a Tertiary Care Hospital in Japan. Int J Infect Dis. 2020 Mar 20;95:210-215.
  26. Kawakami N, Namkoong H, Masaki K, Kurebayashi Y, Shimoda M, Kotani H, Fujiwara H, Hasegawa N. IL-6 and G-CSF production resulting from lung cancer in an HIV patient. IDCases. e00693,2020.
  27. Kawakami N, Namkoong H, Shimoda M, Kotani H, Fujiwara H, Hasegawa N. Hidden disseminated extracutaneous AIDS-related Kaposi sarcoma. IDCases. 19: e00716, 2020.
  28. Toyama T, Mori T, Kato J, Sugita K, Hasegawa N, Nakata N, Hoshino Y, Okamoto S. Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation. Transplant Infectious Disease. e13278,2020.
  29. Miyama H, Takatsuki S, Fukano H, Uwamino Y, Hasegawa N. Infection of a Cardiac Implantable Electronic Device Caused by Mycolicibacterium litorale. JACC: Case Reports. 2(2), 2020.